SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-21-017949
Filing Date
2021-07-29
Accepted
2021-07-29 21:32:44
Documents
2
Period of Report
2021-07-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1470
2 buckheitpoa.htm EX-24 10445
  Complete submission text file 0001437749-21-017949.txt   13379
Mailing Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526
Business Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526 (888) 613-8802
Cytocom, Inc. (Issuer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYTOCOM INC. 2537 RESEARCH BLVD, SUITE 201 FORT COLLINS CO 80526
Business Address
Buckheit Robert (Reporting) CIK: 0001871727 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32954 | Film No.: 211129729